Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
TXMD holding history
TherapeuticsMD, Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −610−100.0% | Sold outConverted for a 1-for-50 split | Holders |
| Q1 2022 | 30,500 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 30,500 | $11.0K | <0.1% | −2,000−6.2% | Reduced | Holders |
| Q3 2021 | 32,500 | $24.0K | <0.1% | −3,950−10.8% | Reduced | Holders |
| Q2 2021 | 36,450 | $43.0K | <0.1% | +1,150+3.3% | Added | Holders |
| Q1 2021 | 35,300 | $47.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.